[1]孙 甫,兰翠茹,熊卫平,等.铅门跟随技术对食管癌调强放疗计划质控的影响[J].医学信息,2022,35(04):133-136.[doi:10.3969/j.issn.1006-1959.2022.04.034]
 SUN Fu,LAN Cui-ru,XIONG Wei-ping,et al.The Impact of Jaw Tracking Technique on Plan Quality Assurance of Intensity-modulatedRadiotherapy for esophageal cancer[J].Medical Information,2022,35(04):133-136.[doi:10.3969/j.issn.1006-1959.2022.04.034]
点击复制

铅门跟随技术对食管癌调强放疗计划质控的影响()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年04期
页码:
133-136
栏目:
临床研究
出版日期:
2022-02-15

文章信息/Info

Title:
The Impact of Jaw Tracking Technique on Plan Quality Assurance of Intensity-modulatedRadiotherapy for esophageal cancer
文章编号:
1006-1959(2022)04-0133-04
作者:
孙 甫12兰翠茹12熊卫平12李 丛3吴府容3
1.重庆市江津区肿瘤医院肿瘤科,重庆 402289;2.重庆市江津区第二人民医院肿瘤科,重庆 402289;3.重庆大学附属肿瘤医院肿瘤放射治疗中心,重庆 400030
Author(s):
SUN Fu12LAN Cui-ru12XIONG Wei-ping12LI Cong3WU Fu-rong3
1.Department of Oncology,the Cancer Hospital of Jiangjin District,Chongqin 402289,China;2.Department of Oncology,the Second People’s Hospital of Jiangjin District,Chongqin 402289,China;3.Department of Radiation Oncology,Chongqing University Cancer Hospi
关键词:
食管癌调强放疗放射性肺炎计划质控
Keywords:
Esophageal cancerIntensity-modulated radiotherapyRadiation pneumonitisPlan quality assurance
分类号:
R735.1;R811.1
DOI:
10.3969/j.issn.1006-1959.2022.04.034
文献标志码:
A
摘要:
目的 研究铅门自动跟随技术对食管癌调强放疗计划的质控效果以及对放射性肺炎剂量体积指标的影响。方法 选择我院2019年9月-2020年12月收治的胸中段食管癌患者20例,分别采用铅门跟随技术和铅门固定技术对患者的放疗计划进行重新设计,根据患者的放疗计划将其分为铅门跟随技术组和铅门固定技术组,制定两种技术条件下的治疗计划,比较两组PTV、心脏、脊髓、肺及肺相关指标(V5、V10、V20、V30和V40)的剂量曲线,比较两组计划的靶区、危及器官和虚拟器官的γ通过率。结果 两组PTV、心脏、脊髓、肺及肺相关指标(V5、V10、V20、V30和V40)的剂量曲线基本一致;铅门跟随技术组中PTV和肺的γ通过率比铅门固定技术组中分别小0.55%和0.05%,铅门跟随技术组中虚拟器官V5、V10、V20、V30和V40,Spared的γ通过率比铅门固定技术组中分别小0.04%、0.04%、0.09%、0.13%和0.09%,但差异均无统计学意义(P>0.05);铅门跟随技术组中心脏的γ通过率比铅门固定技术组的大0.09%,但差异无统计学意义(P>0.05)。结论 铅门跟随技术对食管癌调强放疗的计划质控和放射性肺炎剂量体积指标无明显影响,两方法均可用于临床治疗。
Abstract:
Objective To study the quality control effect of jaw tracking technique on esophageal cancer intensity modulated radiotherapy plan and its effect on radiation pneumonitis dose volume index.Methods A total of 20 patients with middle thoracic esophageal cancer admitted to our hospital from September 2019 to December 2020 were selected, and the radiotherapy plans of the patients were redesigned by using the jaw tracking technique and the fixed jaw technique, respectively. According to the radiotherapy plans of the patients, they were divided into the jaw tracking technique group and the fixed jaw technique group, and the treatment plans under the two technical conditions were formulated. The dose curves of PTV, heart, spinal cord, lung and lung-related indicators (V5, V10, V20, V30 and V40) in the two groups were compared, and the γ pass rates of target areas, organs at risk and virtual organs in the two groups were compared.Results The dose curves of PTV, heart, spinal cord, lung and lung related indexes (V5, V10, V20, V30 and V40) in the two groups were basically the same.The values of γ passing rates of PTV and lungs were 0.55% and 0.05% in jaw tracking technique group, which were lower than those in fixed jaw technique group. The rates calculated for virtual organs V5, V10, V20, V30 and V40,spared were 0.04%、0.04%、0.09%、0.13% and 0.09% lower in jaw tracking technique group than that in the relative rates calculated with fixed jaw technique group, respectively, but the difference was not statistically significant (P>0.05). The γ passing rates of heart was 0.09% higher with jaw tracking technique group than that with fixed jaw technique group, but the difference was not statistically significant (P>0.05).Conclusion Jaw tracking technique had no significant impact on the plan quality assurance and dosimetric/volumetric factors associated with radiation pneumonitis in intensity-modulated radiotherapy for esophageal cancer, both methods can be used for clinical treatment.

参考文献/References:

[1]Stahl M,Mariette C,Haustermans K,et al.Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J].Ann Oncol,2016,27(suppl 5):v50-v57. [2]Shah MA,Kennedy EB,Catenacci DV,et al.Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline[J].J Clin Oncol,2020,38(23):2677-2694. [3]中国临床肿瘤学会指南工作委员会.中国临床肿瘤学会(CSCO)食管癌诊疗指南2020版[M]北京:人民卫生出版社,2020.[4]Koide Y,Kodaira T,Tachibana H,et al.Clinical outcome of definitive radiation therapy for superficial esophageal cancer[J].Jpn J Clin Oncol,2017,47(5):393-400. [5]朱林,袁高峰,胡筱,等.白蛋白紫杉醇联合顺铂方案同步放化疗治疗局部晚期食管癌的临床观察[J].临床肿瘤学杂志,2020,25(10):916-920.[6]杨燕,李建成,王胜强,等.同步放化疗与序贯化放疗治疗中晚期食管癌的临床观察[J].临床肿瘤学杂志,2018,23(3):251-254.[7]Briere TM,Krafft S,Liao Z,et al.Lung Size and the Risk of Radiation Pneumonitis[J].Int J Radiat Oncol Biol Phys,2016,94(2):377-384.[8]Lu WM,Gao Z,Li C,et al.Computed tomography-based delta-radiomics analysis for discriminating radiation pneumonitis in patients with esophageal cancer after radiation therapy[J].Int J Radiat Oncol Biol Phys,2021,111(2):443-455. [9]Yang LT,Zhou L,Chen L,et al.Establishment and Verification of a Prediction Model for Symptomatic Radiation Pneumonitis in Patients with Esophageal Cancer Receiving Radiotherapy[J].Med Sci Monit,2021(27):e930515. [10]汪盛,王彩莲,范丽华.老年食管癌患者三维适形放疗后发生放射性肺炎与剂量体积参数的相关性[J].肿瘤防治研究,2021,48(2):173-177.[11]张帆,叶冬青,唐虹,等.食管癌调强放疗中肺损伤的剂量学因素探究[J].安徽医科大学学报,2009(5):628-630.[12]杜峰,王强,王玮,等.胸段食管癌放疗后放射性肺炎相关因素分析[J].中华放射医学与防护杂志,2020,40(11):832-839.[13]Wu H,Jiang F,Yue H,et al.A comparative study of identical VMAT plans with and without jaw tracking technique[J].J Appl Clin Med Phys,2016,17(5):133-141.[14]杨含,钟明松,吴府容,等.胸中段食管癌共面不等分5野及铅门跟随调强放疗计划的剂量学研究[J].中国医学物理学杂志,2018,37(7):810-815.[15]谢家存,裴运通,梁恒坡,等.铅门跟随与铅门固定在非小细胞肺癌调强放疗的剂量学比较[J].国际医药卫生导报,2018,24(11):1640-1642.[16]成树林,宾石珍,单冬勇,等.铅门跟随技术与铅门固定技术在乳腺癌根治术后调强放疗中的剂量学比较[J].中国医学物理学杂志,2017,34(5):480-483. [17]冯仲苏,吴昊,蒋璠,等.铅门跟随技术与铅门固定技术在直肠癌术前调强放疗中的剂量学比较[J].中华放射医学与防护杂志,2014,34(12):938-941.[18]Aboulbanine Z,Khayati NE.Validation of a virtual source model of medical linac for Monte Carlo dose calculation using multi-threaded Geant4[J].Phys Med Biol,2018,63(8):085008. [19]Hoffmann L,Alber M,S?觟hn M,et al.Validation of the Acuros XB dose calculation algorithm versus Monte Carlo for clinical treatment plans[J].Med Phys,2018,45(8):3909-3015.[20]de Boer HCJ,Heijmen BJM.eNAL: An extension of the nal setup correction protocol for effective use of weekly follow-up measurements[J].Int J Radiat Oncol Biol Phys,2007,67(5):1586-1595.[21]Kumar L,Yadav G,Kishore V,et al.Dosimetric validation of Acuros XB photon dose calculation algorithm on an indigenously fabricated low-density heterogeneous phantom[J].Radiation Protection and Environment,2019,42(4):173-179.[22]Ashfaq Z,Basim KM,Amjad H.A comparison of Monte Carlo, anisotropic analytical algorithm (AAA) and Acuros XB algorithms in assessing dosimetric perturbations during enhanced dynamic wedged radiotherapy deliveries in heterogeneous media[J].Journal of Radiotherapy in Practice,2018,18(1):1-7.

相似文献/References:

[1]汪 兵,杜 铭.食管癌微创手术与机器人手术的研究[J].医学信息,2018,31(06):34.[doi:10.3969/j.issn.1006-1959.2018.06.012]
 WANG Bing,DU Ming.Study on Minimally Invasive Surgery and Robotic Surgery for Esophageal Carcinoma[J].Medical Information,2018,31(04):34.[doi:10.3969/j.issn.1006-1959.2018.06.012]
[2]茹仙古丽·艾尔西丁,木拉提·哈米提,严传波,等.RF和C4.5决策树在食管癌图像分类中的研究[J].医学信息,2018,31(22):51.[doi:10.3969/j.issn.1006-1959.2018.22.015]
 Roxangvl·Arxidin,Murat·Hamit,YAN Chuan-bo,et al.Research on RF and C4.5 Decision Tree in Image Classification of Esophageal Cancer[J].Medical Information,2018,31(04):51.[doi:10.3969/j.issn.1006-1959.2018.22.015]
[3]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
 WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Medical Information,2018,31(04):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
[4]张小艳,赵 红,郑穗生,等.食管癌患者放射性肺损伤预测因素分析及其与 COPD的相关性研究[J].医学信息,2019,32(14):68.[doi:10.3969/j.issn.1006-1959.2019.14.022]
 ZHANG Xiao-yan,ZHAO Hong,ZHENG Sui-sheng,et al.Predictive Factors Analysis of Radiation-Induced Lung Injury in Patients with Esophageal Cancer and Its Correlation with COPD[J].Medical Information,2019,32(04):68.[doi:10.3969/j.issn.1006-1959.2019.14.022]
[5]杨玥欣,汪 志,杨 欣,等.食管癌放疗的剂量学和临床疗效研究[J].医学信息,2020,33(04):72.[doi:10.3969/j.issn.1006-1959.2020.04.022]
 YANG Yue-xin,WANG Zhi,YANG Xin,et al.Dosimetry and Clinical Efficacy of Radiotherapy for Esophageal Cancer[J].Medical Information,2020,33(04):72.[doi:10.3969/j.issn.1006-1959.2020.04.022]
[6]陈健康,王春光.热塑体膜加温在乳腺癌根治术后调强放疗中的应用[J].医学信息,2020,33(12):94.[doi:10.3969/j.issn.1006-1959.2020.12.027]
 CHEN Jian-kang,WANG Chun-guang.Application of Thermoplastic Body Film Heating in Intensity-modulated Radiotherapy After Radical Mastectomy[J].Medical Information,2020,33(04):94.[doi:10.3969/j.issn.1006-1959.2020.12.027]
[7]刘安东,刘崇华,王园园.参麦注射液联合放射治疗对中晚期食管癌老年患者的疗效[J].医学信息,2020,33(16):152.[doi:10.3969/j.issn.1006-1959.2020.16.048]
 LIU An-dong,LIU Chong-hua,WANG Yuan-yuan.The Effect of Shenmai Injection Combined with Radiotherapy on Elderly Patients with Advanced Esophageal Cancer[J].Medical Information,2020,33(04):152.[doi:10.3969/j.issn.1006-1959.2020.16.048]
[8]赵素素,谭洁琼,党 娟.食管癌术后恢复期补液量与术后恢复的关系[J].医学信息,2021,34(04):88.[doi:10.3969/j.issn.1006-1959.2021.04.023]
 ZHAO Su-su,TAN Jie-qiong,DANG Juan.The Relationship Between the Amount of Fluid Supplementation in the Recovery Period and Postoperative Recovery of Esophageal Cancer[J].Medical Information,2021,34(04):88.[doi:10.3969/j.issn.1006-1959.2021.04.023]
[9]郑仁超,郑祖安,刘 琪,等.自粘性组织等效膜在乳腺癌调强放疗中的应用[J].医学信息,2021,34(04):110.[doi:10.3969/j.issn.1006-1959.2021.04.029]
 ZHENG Ren-chao,ZHENG Zu-an,LIU Qi,et al.Application of Self-adhesive Tissue Equivalent Membrane in Intensity-modulated Radiotherapy of Breast Cancer[J].Medical Information,2021,34(04):110.[doi:10.3969/j.issn.1006-1959.2021.04.029]
[10]吴伯勋,刘 浩,刘洪利.香砂六君子汤在微创食管癌切除术后肠功能恢复中的应用效果[J].医学信息,2021,34(06):169.[doi:10.3969/j.issn.1006-1959.2021.06.045]
 WU Bo-xun,LIU Hao,LIU Hong-li.Application Effect of Xiangsha Liujunzi Decoction in Recovery of Bowel Function After Minimally Invasive Esophageal Cancer Resection[J].Medical Information,2021,34(04):169.[doi:10.3969/j.issn.1006-1959.2021.06.045]
[11]许益芬.三维适型放疗与调强放疗在胸中段食管癌根治性放疗中的 剂量学比较[J].医学信息,2018,31(13):73.[doi:10.3969/j.issn.1006-1959.2018.13.021]
 XU Yi-fen.Dosimetric Comparison of Three-dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Radical Radiotherapy of Middle Thoracic Esophageal Carcinoma[J].Medical Information,2018,31(04):73.[doi:10.3969/j.issn.1006-1959.2018.13.021]

更新日期/Last Update: 1900-01-01